These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 10971047)

  • 1. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A
    Dement Geriatr Cogn Disord; 2000 Sep; 11 Suppl 1():11-8. PubMed ID: 10971047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease.
    Albuquerque EX; Santos MD; Alkondon M; Pereira EF; Maelicke A
    Alzheimer Dis Assoc Disord; 2001 Aug; 15 Suppl 1():S19-25. PubMed ID: 11669505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A; Schrattenholz A; Samochocki M; Radina M; Albuquerque EX
    Behav Brain Res; 2000 Aug; 113(1-2):199-206. PubMed ID: 10942046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic cholinergic modulation: galantamine as a prototype.
    Woodruff-Pak DS; Lander C; Geerts H
    CNS Drug Rev; 2002; 8(4):405-26. PubMed ID: 12481195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A; Albuquerque EX
    Eur J Pharmacol; 2000 Mar; 393(1-3):165-70. PubMed ID: 10771010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology.
    Coyle JT; Geerts H; Sorra K; Amatniek J
    J Alzheimers Dis; 2007 Jul; 11(4):491-507. PubMed ID: 17656829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.
    Texidó L; Ros E; Martín-Satué M; López S; Aleu J; Marsal J; Solsona C
    Br J Pharmacol; 2005 Jul; 145(5):672-8. PubMed ID: 15834443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine: additional benefits to patients with Alzheimer's disease.
    Lilienfeld S; Parys W
    Dement Geriatr Cogn Disord; 2000 Sep; 11 Suppl 1():19-27. PubMed ID: 10971048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
    Dajas-Bailador FA; Heimala K; Wonnacott S
    Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
    Schilström B; Ivanov VB; Wiker C; Svensson TH
    Neuropsychopharmacology; 2007 Jan; 32(1):43-53. PubMed ID: 16641937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
    Noda Y; Mouri A; Ando Y; Waki Y; Yamada SN; Yoshimi A; Yamada K; Ozaki N; Wang D; Nabeshima T
    Int J Neuropsychopharmacol; 2010 Nov; 13(10):1343-54. PubMed ID: 20219155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nicotinic Receptor, galantamine and Alzheimer disease].
    Arroyo G; Aldea M; Fuentealba J; García AG
    Rev Neurol; 2002 Jun 1-15; 34(11):1057-65. PubMed ID: 12134305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.
    Wang D; Noda Y; Zhou Y; Mouri A; Mizoguchi H; Nitta A; Chen W; Nabeshima T
    Neuropsychopharmacology; 2007 Jun; 32(6):1261-71. PubMed ID: 17133263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nicotinic acetylcholine receptor in Alzheimer's disease].
    Abe K
    Nihon Rinsho; 2013 Apr; 71(4):743-50. PubMed ID: 23678610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.
    Maelicke A; Samochocki M; Jostock R; Fehrenbacher A; Ludwig J; Albuquerque EX; Zerlin M
    Biol Psychiatry; 2001 Feb; 49(3):279-88. PubMed ID: 11230879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
    Samochocki M; Höffle A; Fehrenbacher A; Jostock R; Ludwig J; Christner C; Radina M; Zerlin M; Ullmer C; Pereira EF; Lübbert H; Albuquerque EX; Maelicke A
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1024-36. PubMed ID: 12649296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.
    Grantham C; Geerts H
    J Neurol Sci; 2002 Nov; 203-204():131-6. PubMed ID: 12417371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease.
    Coyle J; Kershaw P
    Biol Psychiatry; 2001 Feb; 49(3):289-99. PubMed ID: 11230880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy.
    Geerts H; Finkel L; Carr R; Spiros A
    J Neural Transm Suppl; 2002; (62):203-16. PubMed ID: 12456064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.